Kewaunee Scientific Corporation (KEQU)
Official siteCONSUMER CYCLICAL • FURNISHINGS, FIXTURES & APPLIANCES • NASDAQ
Market Cap: $101.49M
Last updated: Nov 17, 2026 at 4:10 PM ET
Kewaunee Scientific Corporation (KEQU) Statistics
Kewaunee Scientific (KEQU) has a market cap of $101.49M and an enterprise value of $112.61M. Its return on invested capital of 12.38% compares with a 3.10% median across 9 similar companies.
Total Valuation
Enterprise value is 10.95% above the market cap, as debt exceeds cash.
| Market Cap | $101.49M |
|---|---|
| Enterprise Value | $112.61M |
| Latest price (Nov 17, 2026) | $34.01 |
Key Dates
The next earnings report is expected on Dec 16, 2026, covering the quarter ending Oct 31, 2026.
| Next Earnings Date | Dec 16, 2026 (expected) |
|---|---|
| Last Earnings Date | Sep 9, 2026 |
| Fiscal Year End | April |
Valuation Ratios
Sales and book value multiples are 0.4x and 1.3x. Its year-end P/E ranged from 7.5x to 17.3x from 2016 to 2025.
| P/E Ratio | 11.9x |
|---|---|
| P/S Ratio | 0.4x |
| P/B Ratio | 1.3x |
| P/TBV Ratio | 2.1x |
| P/FCF Ratio | 9.0x |
| P/OCF Ratio | 6.8x |
Enterprise Valuation
Counting debt and cash, the company is valued at 4.8x EBITDA and 10.0x free cash flow.
| EV / Earnings | 12.3x |
|---|---|
| EV / Sales | 0.4x |
| EV / EBITDA | 4.8x |
| EV / EBIT | 7.1x |
| EV / FCF | 10.0x |
Price Statistics
The stock is down 15.86% over 52 weeks and trades 0.35% above its 50-day average.
| Beta (1Y) | 0.47 |
|---|---|
| 52-Week Change | -15.86% |
| 1-Month Change | +5.95% |
| 3-Month Change | -5.55% |
| 6-Month Change | -11.75% |
| 5-Year Change | +161.25% |
| 10-Year Change | +49.55% |
| Total Return (1Y) | -15.86% |
| Total Return (3Y CAGR) | +22.58% |
| Total Return (5Y CAGR) | +21.79% |
| Return vs SPY (1Y) | -25.37% |
| Max Drawdown (1Y) | -25.52% |
| Max Drawdown (3Y) | -55.36% |
| Sharpe Ratio (1Y) | -0.42 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $33.89 |
| 200-Day Average | $36.52 |
| 52-Week Range | $32.00 to $43.36 |
| RSI (14 Days) | 49.9 |
| Average Volume (20 Days) | 5.23K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.20x current liabilities, and total debt is 0.26x shareholder equity.
| Current Ratio | 2.20x |
|---|---|
| Quick Ratio | 1.57x |
| Debt / Equity | 0.26x |
| Debt / EBITDA | 0.85x |
| Debt / FCF | 1.78x |
| Interest Coverage | 4.61x |
Returns and Efficiency
Return on invested capital is 12.38% over the last 12 months, against a 5-year average of 17.91%.
| Return on Equity (ROE) | 12.20% |
|---|---|
| Return on Assets (ROA) | 5.20% |
| Return on Invested Capital (ROIC) | 12.38% |
| Return on Capital Employed (ROCE) | 12.29% |
| ROE (5Y Average) | 10.72% |
| ROA (5Y Average) | 4.41% |
| ROIC (5Y Average) | 17.91% |
| Asset Turnover | 1.50x |
| Inventory Turnover | 6.57x |
| Receivables Turnover | 4.74x |
| Cash Conversion Cycle | 92 days |
Taxes
Income tax took 26.06% of pretax income over the last 12 months.
| Income Tax (TTM) | $3.22M |
|---|---|
| Effective Tax Rate | 26.06% |
Scores
KEQU has an Altman Z-Score of 3.42, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.42 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $277.21M over the last 12 months is up 5.33% from the 12 months before.
| Revenue | $277.21M |
|---|---|
| Revenue Growth (YoY) | +5.33% |
| Gross Profit | $79.15M |
| Operating Income | $15.06M |
| Pretax Income | $12.37M |
| Net Income | $9.15M |
| EBITDA | $22.66M |
| EBIT | $15.80M |
| Reported EPS (TTM) | $2.86 |
Trailing 12 months through Jul 31, 2026.
Balance Sheet
Shareholder equity funds 42.66% of the $175.80M in total assets.
| Cash and Equivalents | $8.25M |
|---|---|
| Total Debt | $19.36M |
| Net Debt | $11.12M |
| Net Debt Per Share | $3.86 |
| Working Capital | $56.72M |
| Shareholder Equity | $75.00M |
| Book Value Per Share | $26.04 |
| Tangible Book Value | $46.61M |
| Tangible Book Per Share | $16.18 |
| Total Assets | $175.80M |
| Total Liabilities | $98.58M |
Balance sheet as of Jul 31, 2026.
Cash Flow
After $3.94M of capital spending, operating cash flow left $10.88M of free cash flow.
| Operating Cash Flow | $14.82M |
|---|---|
| Capital Expenditures | $3.94M |
| Free Cash Flow | $10.88M |
| FCF Per Share | $3.76 |
| Depreciation and Amortization | $6.85M |
Trailing 12 months through Jul 31, 2026.
Margins
The operating margin is 5.43%, against a 5-year average of 4.64%.
| Gross Margin | 28.55% |
|---|---|
| Operating Margin | 5.43% |
| Pretax Margin | 4.46% |
| Net Margin | 3.30% |
| EBITDA Margin | 8.17% |
| EBIT Margin | 5.70% |
| FCF Margin | 3.92% |
| Gross Margin (5Y Average) | 22.65% |
| Operating Margin (5Y Average) | 4.64% |
| Net Margin (5Y Average) | 2.99% |
Growth
Revenue grew 8.71% a year over 3 years, and EPS 141.55% a year.
| Revenue Growth (3Y CAGR) | +8.71% |
|---|---|
| Revenue Growth (5Y CAGR) | +13.84% |
| EPS Growth (3Y CAGR) | +141.55% |
| Operating Income Growth (3Y CAGR) | +46.06% |
| Book Value Per Share Growth (2Y CAGR) | +16.36% |
| Tangible Book Per Share Growth (2Y CAGR) | -8.76% |
Dividends and Yields
KEQU does not pay a dividend. Its free cash flow yield is 11.11%.
| Earnings Yield | 8.40% |
|---|---|
| FCF Yield | 11.11% |
| Buyback Yield | 0.54% |
Peer Position
Against 7 similar companies, KEQU has the 4th highest P/E.
P/E RatioPeer median 11.5x
P/S RatioPeer median 0.5x
ROICPeer median 3.10%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +0.48%
| P/E Ratio | 11.9x vs 11.5x median |
|---|---|
| P/S Ratio | 0.4x vs 0.5x median |
| ROIC | 12.38% vs 3.10% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.33% vs +0.48% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About KEQU
What is KEQU's market cap?
Kewaunee Scientific has a market cap of $101.49M. Its enterprise value, which adds debt and subtracts cash, is $112.61M.
What is KEQU's P/E ratio?
Kewaunee Scientific has a trailing P/E ratio of 11.9x.
How many shares of KEQU are outstanding?
Kewaunee Scientific has 2.88M shares outstanding. The count is up 1.02% from a year earlier.
Does KEQU pay a dividend?
No. Kewaunee Scientific does not pay a dividend.
How much debt does KEQU have?
Kewaunee Scientific has $19.36M of total debt and $8.25M of cash and equivalents, a net debt position of $11.12M.
KEQU pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors